1. Mulcahy, KP, Langdon, PC, Mastalgia, F. Dysphagia in inflammatory myopathy: self-report, incidence and prevalence. Dysphagia. 2012;27:64-69.
Google Scholar | Crossref | Medline2. Oh, TH, Brumfield, KA, Hoskin, TL, Stolp, KA, Murray, JA, Bassford, JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcomes in 62 patients. Mayo Clin Proc. 2007;82(4):441-447.
Google Scholar | Crossref | Medline | ISI3. Mugii, N, Hasegawa, M, Matsushita, T, et al. Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS ONE. 2016;11(5):e0154746. doi:10.1371/journal.pone.0154746.
Google Scholar | Crossref | Medline4. Mohannak, N, Pattison, G, Hird, K, Needham, M. Dysphagia in patients with sporadic inclusion body myositis: management challenges. Int J Gen Med. 2019;12:465-474.
Google Scholar | Crossref | Medline5. Williams, RB, Grehan, MJ, Hersch, M, Andre, J, Cook, IJ. Biomechanics, diagnosis, and treatment outcome in inflammatory myopathy presenting as oropharyngeal dysphagia. Gut. 2003;52:471-478.
Google Scholar | Crossref | Medline | ISI6. Ponyi, A, Constantin, T, Garami, M, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005;1051:64-71.
Google Scholar | Crossref | Medline | ISI7. Azuma, K, Yamada, H, Ohkubo, M, et al. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol. 2011;21:178-183. doi:10.1007/s10165-010-0362-y.
Google Scholar | Crossref | Medline | ISI8. Gadiparthi, C, Hans, A, Potts, K, Ismail, MK. Gastrointestinal and hepatic disease in the inflammatory myopathies. Rheum Dis Clin N Am. 2018;44:113-129.
Google Scholar | Crossref | Medline9. Ebert, EC . Review article: the gastrointestinal complications of myositis. Aliment Pharmacol Ther. 2010;31(3):359-365.
Google Scholar | Crossref | Medline10. Satoh, M, Tanaka, S, Ceribelli, A, Calise, SJ, Chan, EK. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol. 2017;52(1):1-19.
Google Scholar | Crossref | Medline11. Barbiera, F, Condello, S, De Palo, A, Todaro, D, Mandracchia, C, De Cicco, D. Role of videofluorography swallow study in management of dysphagia in neurologically compromised patients. Radiol Med. 2006;111(6):818-827.
Google Scholar | Crossref | Medline12. de Merieux, P, Verity, MA, Clements, PJ, Paulus, HE. Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis Rheum. 1983;26(8):961-968.
Google Scholar | Crossref | Medline13. Casal-Dominguez, N, Pinal-Fernandez, I, Mego, M, et al. High-resolution manometry in patients with idiopathic inflammatory myopathy: elevated prevalence of esophageal involvement and differences according to autoantibody status and clinical subset. Muscle Nerve. 2017;56:386-392.
Google Scholar | Crossref | Medline14. Kwon, KM, Lee, JS, Kim, YH. A case report of life threatening acute dysphagia in dermatomyositis: challenges in diagnosis and treatment. Medicine (Baltimore). 2018;97(17):e0508.
Google Scholar | Crossref | Medline15. Marie, I, Menard, JF, Hatron, PY, et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res (Hoboken). 2010;62(12):1748-1755.
Google Scholar | Crossref | Medline